November 13, 2026 · Journal of cataract and refractive surgery · DOI: 10.1097/j.jcrs.0000000000002102

12-month visual and safety outcomes of the ELIOS procedure with cataract surgery in primary open-angle glaucoma.

Listen to this summary

This prospective, multicenter, non-randomized trial asked whether combining phacoemulsification with ELIOS excimer laser trabeculostomy is safe and visually sound for patients with cataract and mild-to-moderate primary open-angle glaucoma over 12 months. Among 318 patients, visual acuity was preserved or improved in nearly all cases (no losses of two or more lines, with 69.8% gaining at least one line), and endothelial cell loss stabilized after an early decline (median -9.10% at 12 months). Most postoperative adverse events were early and self-limited, with the most common being anterior chamber inflammation (5.7%) and visual field mean deviation worsening (4.4%), a safety profile the authors describe as consistent with phacoemulsification alone.

Steven Sarkisian, Mark Gallardo, George Reiss, Andy Lee, Paul Singh, Navaneet Borisuth, Mohamed Yassine, Kelly Swaim, Cathleen McCabe, Yi-Jing Duh, Hsin Yi Ling, Rupali Nangia, Iqbal Ike K Ahmed

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play